Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eloxx Pharmaceuticals Inc (DE:397)
FRANKFURT:397
Eloxx Pharmaceuticals (397) Financial Statements
0 Followers
Eloxx Pharmaceuticals Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -7.02M | $ -10.14M | $ -11.22M | $ -11.63M | $ -9.66M |
| EBITDA | $ -6.83M | $ -10.01M | $ -11.02M | $ -11.43M | $ -9.38M |
| Net Income Common Stockholders | $ -7.51M | $ -10.62M | $ -11.62M | $ -12.09M | $ -9.88M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 24.55M | $ 30.05M | $ 39.77M | $ 42.27M | $ 52.43M |
| Total Assets | $ 26.88M | $ 32.94M | $ 43.62M | $ 45.14M | $ 55.38M |
| Total Debt | $ 13.41M | $ 13.44M | $ 13.40M | $ 13.46M | $ 13.54M |
| Net Debt | $ -11.14M | $ -16.61M | $ -26.36M | $ -28.81M | $ -38.89M |
| Total Liabilities | $ 31.86M | $ 31.13M | $ 31.93M | $ 22.75M | $ 22.39M |
| Stockholders Equity | $ -4.98M | $ 1.81M | $ 11.69M | $ 22.38M | $ 33.00M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -6.99M | $ -9.75M | $ -9.50M | $ -9.95M | $ -7.66M |
| Operating Cash Flow | $ -6.95M | $ -9.75M | $ -9.49M | $ -9.93M | $ -7.59M |
| Investing Cash Flow | $ -48.00K | $ -7.00K | $ -11.00K | $ -20.00K | $ -69.00K |
| Financing Cash Flow | $ 1.50M | $ 0.00 | $ 7.00M | $ -160.00K | $ 3.35M |
Eloxx Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.